MRI與CT診斷不同病理分期前列腺癌患者的準(zhǔn)確率對比
[Abstract]:Objective to study the accuracy of MRI and CT in the diagnosis of prostate cancer with different pathological stages. Methods Sixty-one patients with prostate cancer in our hospital were examined by plain / enhanced CT scan (dual phase dynamic scan) and MRI. The accuracy of the two methods in detecting A / B / C / D prostate cancer was compared. Results in this study, there were 61 patients with stage A, 3 patients with stage B, 16 patients with stage C, 18 patients with stage D, 24 patients with stage D. The detection rate of A / B by plain scan / enhanced CT scan was 47.37B, missed diagnosis, misdiagnosis of 10 cases with benign prostatic hyperplasia, 6 cases with misdiagnosis as benign prostatic hyperplasia. In the other 4 cases, the detectable rate of missed MRI was 89.47% for A / B, and 2 cases for missed diagnosis. The detection rate of MRI was significantly higher than that of CT (P0.05) CT plain scan / enhanced scan (P 0.05). The detection rate of C / D in 3 misdiagnosed cases, including 2 cases of benign prostatic hyperplasia and 1 case of bladder cancer, was 95.24%, and 2 cases of misdiagnosis were all diagnosed as benign prostatic hyperplasia. The detection rate was slightly higher than MRI, but the difference was not statistically significant (P0.05). Conclusion the accuracy of MRI in the diagnosis of Aneb stage prostate cancer is significantly higher than that of CT plain scan and enhanced scan. The main reason is that the volume of prostate is increased, the density of prostate is not changed obviously, and the margin is blurred, which has an effect on CT diagnosis. Both methods can accurately detect stage D prostate cancer, which is related to the morphological changes of prostate gland which has been perforated by the tissue of cancer. However, MRI can judge whether the membrane is invaded by cancer cells, so it is more valuable than CT in the diagnosis of prostate cancer.
【作者單位】: 廣東省湛江市第二人民醫(yī)院醫(yī)學(xué)影像科;
【分類號(hào)】:R737.25;R445.2;R730.44
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 何瑋;;~(125)I粒子置入治療前列腺癌患者的護(hù)理[J];護(hù)理學(xué)雜志;2006年02期
2 葉珊;徐文峰;林哲;;高強(qiáng)度聚焦超聲波治療老年前列腺癌患者的護(hù)理[J];護(hù)理學(xué)報(bào);2006年02期
3 陳晶;劉敏;管旌旌;張麗娟;;老年前列腺癌患者內(nèi)分泌治療的心理護(hù)理研究[J];吉林醫(yī)學(xué);2013年22期
4 肖歡;;前列腺癌患者間歇性內(nèi)分泌治療時(shí)的護(hù)理干預(yù)[J];河南醫(yī)學(xué)研究;2014年06期
5 越麗霞;賈立平;張素琴;;接受內(nèi)分泌治療前列腺癌患者的護(hù)理[J];山東醫(yī)藥;2007年12期
6 郭小潔;何衛(wèi);代小燕;;前列腺癌患者強(qiáng)放射治療的護(hù)理[J];航空航天醫(yī)學(xué)雜志;2013年06期
7 楚鑫;孫應(yīng)紅;張媛;;前列腺癌患者抑郁癥狀與社會(huì)支持的相關(guān)性分析及護(hù)理對策[J];四川腫瘤防治;2007年02期
8 崔凌;莊偉雄;文海忠;;DCE-MRI灌注指標(biāo)與MR DWI ADC值在前列腺癌患者中的關(guān)系分析[J];實(shí)用癌癥雜志;2014年05期
9 王永明;老年前列腺癌患者觀察等待階段的生活質(zhì)量及術(shù)后尿失禁處理[J];國外醫(yī)學(xué).護(hù)理學(xué)分冊;2003年10期
10 吳貴玲;;心理護(hù)理對前列腺癌患者預(yù)后的影響[J];河北醫(yī)學(xué);2006年05期
相關(guān)會(huì)議論文 前5條
1 高慧敏;田美麗;;前列腺癌患者健康概念完整性的調(diào)查分析[A];全國腫瘤護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2007年
2 劉榮華;殷海枝;;根治性前列腺癌患者術(shù)后護(hù)理觀察與指導(dǎo)[A];中華護(hù)理學(xué)會(huì)全國腫瘤護(hù)理新進(jìn)展研討會(huì)論文匯編[C];2011年
3 沈默;陶志華;何晶晶;吳偉;鄭哲憲;陳偉;;聯(lián)用免疫磁珠分選和實(shí)時(shí)熒光定量RT-PCR檢測前列腺癌患者外周血微轉(zhuǎn)移[A];中華醫(yī)學(xué)會(huì)第八次全國檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中華醫(yī)學(xué)會(huì)檢驗(yàn)分會(huì)成立30周年慶典大會(huì)資料匯編[C];2009年
4 范曉華;羅玉琴;唐春雨;楊亞梅;羅靜靜;羅紫蘭;;各期前列腺癌患者心理輔導(dǎo)的體會(huì)[A];第十五屆全國泌尿外科學(xué)術(shù)會(huì)議論文集[C];2008年
5 高俊平;;心理護(hù)理在提高前列腺癌患者生存質(zhì)量中的應(yīng)用[A];第十五屆全國泌尿外科學(xué)術(shù)會(huì)議論文集[C];2008年
,本文編號(hào):2119185
本文鏈接:http://sikaile.net/yixuelunwen/yundongyixue/2119185.html